On February 24, 2022 Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, reported that Andrew Allen, M.D., Ph.D., Co-founder, President and Chief Executive Officer will participate in the "Infectious Disease" panel at the Cowen 42nd Annual Health Care Conference, which is being held virtually from March 7 to 9 (Press release, Gritstone Oncology, FEB 24, 2022, View Source [SID1234608929]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Panel Details
Title: Infectious Disease
Date and Time: Wednesday, March 9th from 10:30 – 11:30 a.m. ET

A live webcast of the panel will be accessible via the Investors & Media section of the company’s website at View Source An archived replay will be accessible for 30 days following the event.